Headquarters
29 BIGELOW STREET APT 3, CAMBRIDGE, MA 02139-2394, US
CAMBRIDGE, MA, US
Decoy Therapeutics Inc
From the company
Decoy Therapeutics is pioneering a new category of antivirals called Designable Multi-Antivirals (D-MAVs), single adaptable medicines engineered to target mechanisms many viruses share so one drug can work across many of them. Built on the IMP3ACT peptide conjugate platform, which pairs AI-enabled design with rapid synthesis, the company targets flu, RSV and coronaviruses and is working to advance two programs toward the clinic within 24 months.
Capabilities
Products & services
Where they operate
Location & facilities
Direct lines
Contact
Share quantities, requirements, and timing.
Send requirementsCompany record
Profile information
- Founded
- 2020
- Website
- www.decoytx.com
Source: company website
Start a conversation
Send your requirements
Quantities, certifications, delivery timing, and anything else needed to quote the work.